AU2001256406A1 - Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity - Google Patents

Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity

Info

Publication number
AU2001256406A1
AU2001256406A1 AU2001256406A AU5640601A AU2001256406A1 AU 2001256406 A1 AU2001256406 A1 AU 2001256406A1 AU 2001256406 A AU2001256406 A AU 2001256406A AU 5640601 A AU5640601 A AU 5640601A AU 2001256406 A1 AU2001256406 A1 AU 2001256406A1
Authority
AU
Australia
Prior art keywords
dithiolethione
anethole
preventing
treating drug
induced tendon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256406A
Other languages
English (en)
Inventor
Marie-Odile Christen
Patrice Rat
Jean-Michel Warnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Medical SAS
Original Assignee
Solvay Pharma SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharma SAS filed Critical Solvay Pharma SAS
Publication of AU2001256406A1 publication Critical patent/AU2001256406A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Lubricants (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
AU2001256406A 2000-04-25 2001-04-25 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity Abandoned AU2001256406A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0005247A FR2807944B1 (fr) 2000-04-25 2000-04-25 Utilisation de l'anethole-dithiolethione dans la prevention et le traitement de la tenotoxicite induite par un medicament
FR00/05247 2000-04-25
PCT/FR2001/001268 WO2001080856A2 (fr) 2000-04-25 2001-04-25 Utilisation de l'anethole-dithiolethione dans la prevention et le traitement de la tenoxicite induite par un medicament

Publications (1)

Publication Number Publication Date
AU2001256406A1 true AU2001256406A1 (en) 2001-11-07

Family

ID=8849561

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256406A Abandoned AU2001256406A1 (en) 2000-04-25 2001-04-25 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity

Country Status (12)

Country Link
US (1) US20030187067A1 (de)
EP (1) EP1351680B8 (de)
JP (1) JP2003531172A (de)
AT (1) ATE297727T1 (de)
AU (1) AU2001256406A1 (de)
CA (1) CA2406998A1 (de)
DE (1) DE60111571T2 (de)
ES (1) ES2245361T3 (de)
FR (1) FR2807944B1 (de)
HU (1) HUP0301810A2 (de)
PT (1) PT1351680E (de)
WO (1) WO2001080856A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103113360B (zh) * 2013-02-19 2015-01-28 东南大学 一种阿托伐他汀衍生物、其药物组合物及制药应用
US11554106B2 (en) * 2017-03-07 2023-01-17 Marc Childs Prevention of the risks associated with drug-induced QT interval prolongation by using a specific inhibitor of the production of ROS of miochondrial origin
WO2018162846A1 (fr) * 2017-03-07 2018-09-13 Sauzieres, Jacques Prévention des effets adverses des especes reactives de l'oxygene d'origine mitochondriale à l'aide d'un inhibiteur specifique de la production de ros d'origine mitochondriale

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9601808A3 (en) * 1995-07-03 2000-06-28 Sankyo Co Treatment of arteriosclerosis and xanthoma

Also Published As

Publication number Publication date
FR2807944B1 (fr) 2003-06-13
ES2245361T3 (es) 2006-01-01
EP1351680B8 (de) 2005-08-17
EP1351680A2 (de) 2003-10-15
HUP0301810A2 (hu) 2003-09-29
CA2406998A1 (fr) 2001-11-01
PT1351680E (pt) 2005-10-31
DE60111571T2 (de) 2006-05-11
ATE297727T1 (de) 2005-07-15
JP2003531172A (ja) 2003-10-21
DE60111571D1 (de) 2005-07-21
WO2001080856A2 (fr) 2001-11-01
WO2001080856A3 (fr) 2003-04-24
US20030187067A1 (en) 2003-10-02
FR2807944A1 (fr) 2001-10-26
EP1351680B1 (de) 2005-06-15

Similar Documents

Publication Publication Date Title
MXPA03001001A (es) Derivados anticonvulsionantes utiles para el tratameinto de la depresion.
AU2002343557A1 (en) Substituted aryl 1,4-pyrazine derivatives
SI0797439T1 (en) Use of pramipexole as a neuroprotective agent
AU6613896A (en) Chemical compounds
AU4086101A (en) Sulphonamido-substituted bridged bicycloalkyl derivatives
WO2003022214A3 (en) Piperazine and homopiperazine compounds
AU2001282399A1 (en) Resorcinol derivatives
WO2002030353A3 (en) NF-λB INHIBITORS
AU2001260880A1 (en) Pharmaceutical compounds for treating copd
BR9804027A (pt) Novos beta-ceto ésteres
AU2002365222A1 (en) Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases
MX9601994A (es) Profarmacos de derivados de paclitaxel.
MXPA04003755A (es) Endoprotesis vasculares.
IL154776A0 (en) Method for the preparation of 21-hydroxy-6, 19-oxidoprogesterone and derivatives thereof
WO2001002373A8 (fr) Dihydrobenzodiazepines et leur utilisation dans le traitement de dyslipidemies
GB9907571D0 (en) Compounds
WO2002043715A3 (de) Verwendung von 1-phenyl-3-dimethylamino-propanverbindungen zur therapie der harninkontinenz
EP1351680B8 (de) Verwendung von anethol-dithiolethion zur vorbeugung und behandlung der sehnentoxizität
MXPA02007173A (es) Compuestos calciliticos.
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
EP1467978A4 (de) "verbindungen, die bauchspeicheldrüsenlipase hemmen, deren synthese und verwendung "
AU2003285485A1 (en) 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION
AU2002230579A1 (en) Calcilytic compounds
WO2002043714A3 (de) Verwendung von substituierten 6-dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur therapie der harninkontinenz
IL139144A0 (en) Mycobacterial inhibitors